Effects of Type I collagen and fibronectin on regulation of breast cancer cell biological and biomechanical characteristics

Journal of Medical and Biological Engineering

Volumn 34, Issue 1, 2014, Pages 62-68

  Teng, Yanqun ^a,b   Qiu, Juhui ^a,b   Zheng, Yiming ^a   Luo, Xiangdong ^b,c   Zhang, Linlin ^b,c   Chen, Li ^b,c   Wang, Guixue ^a  

^a CHONGQING UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c National Key Laboratory of Trauma and Burns   (China)

Author keywords

Breast cancer; Cell elasticity; Fibronectin (FN); Syndecans; Type I collagen (Col I)

Indexed keywords

BREAST CANCER; CELL ELASTICITY; FIBRONECTIN (FN); SYNDECANS; TYPE I COLLAGEN;

ANTIBODIES; ATOMIC FORCE MICROSCOPY; BIOMECHANICS; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; DISEASES; ELASTIC MODULI; ELASTICITY;

CELLS;

ANTIBODY; COLLAGEN TYPE 1; RECOMBINANT FIBRONECTIN; RECOMBINANT PROTEIN; SYNDECAN 1; SYNDECAN 4; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOMECHANICS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; ELASTICITY; HUMAN; HUMAN CELL; INCUBATION TIME; MOLECULAR BIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; YOUNG MODULUS;

EID: 84896883352     PISSN: 16090985     EISSN: None     Source Type: Journal    
DOI: 10.5405/jmbe.1136     Document Type: Article

References (38)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward and D. Forman, "Global cancer statistics," CA-Cancer J. Clin., 61: 69-90, 2011.
2. A. Sánchez-Muñoz, E. Pérez-Ruiz, N. Ribelles, A. Marquez and E. Alba, "Maintenance treatment in metastatic breast cancer," Expert Rev. Anticancer Ther., 8: 1907-1912, 2008.
3. S. F. Badylak, "The extracellular matrix as a scaffold for tissue reconstruction," Semin. Cell Dev. Biol., 13: 377-383, 2002.
4. C. M. Williams, A. J. Engler, R. D. Slone, L. L. Galante and J. E. Schwarzbauer, "Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation," Cancer Res., 68: 3185-3192, 2008.
5. T. M. Casey, J. Eneman, A. Crocker, J. White, J. Tessitore, M. Stanley, S. Harlow, J. Y. Bunn, D. Weaver, H. Muss and K. Plaut, "Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study," Breast Cancer Res. Treat., 110: 39-49, 2008.
6. A. Lochter and M. J. Bissell, "Involvement of extracellular matrix constituents in breast cancer," Semin. Cancer Biol., 6: 165-173, 1995.
7. W. Gorczyca, R. Holm and J. M. Nesland, "Laminin production and fibronectin immunoreactivity in breast carcinomas," Anticancer Res., 13: 851-858, 1993.
8. E. Ioachim, S. Kamina, M. Kontostolis and N. J. Agnantis, "Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer," Virchows Arch., 431: 311-316, 1997.
9. D. Docheva, D. Padula, M. Schieker and H. Clausen-Schaumann, "Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells," Biochem. Biophys. Res. Commun., 402: 361-366, 2010.
10. S. Suresh, "Biomechanics and biophysics of cancer cells," Acta. Mater., 55: 3989-4014, 2007.
11. S. E. Cross, Y. S. Jin, J. Rao and J. K. Gimzewski, "Nanomechanical analysis of cells from cancer patients," Nat. Nanotechnol., 2: 780-783, 2007.
12. M. Lekka, K. Pogoda, J. Gostek, O. Klymenko, S. Prauzner-Bechcicki, J. Wiltowska-Zuber, J. Jaczewska, J. Lekki and Z. Stachura, "Cancer cell recognition-Mechanical phenotype," Micron, 43: 1259-1266, 2012.
13. M. D. Bass and M. J. Humphries, "Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling," Biochem. J., 368: 1-15, 2002.
14. F. Zong, E. Fthenou, F. Mundt, T. Szatmari, I. Kovalszky, L. Szilak, D. Brodin, G. Tzanakakis, A. Hjerpe and K. Dobra, "Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration," PLoS One, 6: e14816, 2011.
15. C. L. Hall, C. W. Dubyk, T. A. Riesenberger, D. Shein, E. T. Keller and K. L. Van Golen, "Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RhoC GTPase," Neoplasia, 10: 797-803, 2008.
16. J. Qiu, G. Wang, Q. Peng, J. Hu, X. Luo, Y. Zheng, Y. Teng and C. Tang, "Id1 induces tubulogenesis by regulating endothelial cell adhesion and cytoskeletal organization through beta1-integrin and Rho-kinase signalling," Int. J. Mol. Med., 28: 543-548, 2011.
17. C. Feistritzer, N. C. Kaneider, D. H. Sturn and C. J. Wiedermann, "Syndecan-4-dependent migration of human eosinophils," Clin. Exp. Allergy., 34: 696-703, 2004.
18. M. E. Lendorf, T. Manon-Jensen, P. Kronqvist, H. A. Multhaupt and J. R. Couchman, "Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma," J. Histochem. Cytochem., 59: 615-629, 2011.
19. M. Radmacher, M. Fritz, C. M. Kacher, J. P. Cleveland and P. K. Hansma, "Measuring the viscoelastic properties of human platelets with the atomic force microscope," Biophys. J., 70: 556-567, 1996.
20. Q. S. Li, G. Lee, C. N. Ong and C. T. Lim, "AFM indentation study of breast cancer cells," Biochem. Biophys. Res. Commun., 374: 609-613, 2008.
21. P. A. Janmey and R. T. Miller, "Mechanisms of mechanical signaling in development and disease," J. Cell. Sci., 124: 9-18, 2011.
22. S. Ramaswamy, K. N. Ross, E. S. Lander and T. R. Golub, "A molecular signature of metastasis in primary solid tumors," Nat. Genet., 33: 49-54, 2003.
23. P. Provenzano, D. Inman, K. Eliceiri, J. Knittel, L. Yan, C. Rueden, J. White and P. Keely, "Collagen density promotes mammary tumor initiation and progression," BMC Med., 6: 11-25, 2008.
24. K. R. Levental, H. Yu, L. Kass, J. N. Lakins, M. Egeblad, J. T. Erler, S. F. T. Fong, K. Csiszar, A. Giaccia and W. Weninger, "Matrix crosslinking forces tumor progression by enhancing integrin signaling," Cell, 139: 891-906, 2009.
25. E. Ioachim, A. Charchanti, E. Briasoulis, V. Karavasilis, H. Tsanou, D. L. Arvanitis, N. J. Agnantis and N. Pavlidis, "Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression," Eur. J. Cancer, 38: 2362-2370, 2002.
26. D. Barkan, H. Kleinman, J. L. Simmons, H. Asmussen, A. K. Kamaraju, M. J. Hoenorhoff, Z. Liu, S. V. Costes, E. H. Cho and S. Lockett, "Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton," Cancer Res., 68: 6241-6250, 2008.
27. F. G. Giancotti and E. Ruoslahti, "Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells," Cell, 60: 849-859, 1990.
28. M. Bernfield, M. Gotte, P. W. Park, O. Reizes, M. L. Fitzgerald, J. Lincecum and M. Zako, "Functions of cell surface heparan sulfate proteoglycans," Annu. Rev. Biochem., 68: 729-777, 1999.
29. T. Maeda, C. M. Alexander and A. Friedl, "Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells," Cancer Res., 64: 612-621, 2004.
30. N. Yang, R. Mosher, S. Seo, D. Beebe and A. Friedl, "Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility," Am. J. Pathol., 178: 325-335, 2011.
31. W. T. Huang, R. Chiquet-Ehrismann, J. V. Moyano, A. Garcia-Pardo and G. Orend, "Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation," Cancer Res., 61: 8586-8594, 2001.
32. B. D. Cox, M. Natarajan, M. R. Stettner and C. L. Gladson, "New concepts regarding focal adhesion kinase promotion of cell migration and proliferation," J. Cell. Biochem., 99: 35-52, 2006.
33. O. Jonas, C. T. Mierke and J. A. Käs, "Invasive cancer cell lines exhibit biomechanical properties that are distinct from their noninvasive counterparts," Soft Matter, 7: 11488-11495, 2011.
34. K. E. Kasza, A. C. Rowat, J. Liu, T. E. Angelini, C. P. Brangwynne, G. H. Koenderink and D. A. Weitz, "The cell as a material," Curr. Opin. Cell Biol., 19: 101-107, 2007.
35. G. Jiang, A. H. Huang, Y. Cai, M. Tanase and M. P. Sheetz, "Rigidity Sensing at the Leading Edge through αvβ 3 Integrins and RPTPα," Biophys. J., 90: 1804-1809, 2006.
36. A. Fritsch, M. Höckel, T. Kiessling, K. D. Nnetu, F. Wetzel, M. Zink and J. A. Käs, "Are biomechanical changes necessary for tumour progression?" Nat. Phys., 6: 730-732, 2010.
37. O. Kousidou, T. Mitropoulou, A. Roussidis, D. Kletsas, A. Theocharis and N. Karamanos, "Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors," Int. J. Oncol., 26: 1101-1109, 2005.
38. T. Watanabe, H. Kuramochi, A. Takahashi, K. Imai, N. Katsuta, T. Nakayama, H. Fujiki and M. Suganuma, "Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells," J. Cancer Res. Clin. Oncol., 138: 859-866, 2012.